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ABSTRACT
In conventionally-expressed eukaryotic genes, tran-
scription start sites (TSSs) can be identified by
mapping the mature mRNA 50-terminal sequence
onto the genome. However, this approach is not
applicable to genes that undergo pre-mRNA
50-leader trans-splicing (SL trans-splicing) because
the original 50-segment of the primary transcript is
replaced by the spliced leader sequence during the
trans-splicing reaction and is discarded. Thus TSS
mapping for trans-spliced genes requires different
approaches. We describe two such approaches and
show that they generate precisely agreeing results
for an SL trans-spliced gene encoding the muscle
protein troponin I in the ascidian tunicate chordate
Ciona intestinalis. One method is based on experi-
mental deletion of trans-splice acceptor sites and
the other is based on high-throughput mRNA
50-RACE sequence analysis of natural RNA popula-
tions in order to detect minor transcripts containing
the pre-mRNA’s original 50-end. Both methods
identified a single major troponin I TSS located
 460nt upstream of the trans-splice acceptor
site. Further experimental analysis identified a func-
tionally important TATA element 31nt upstream
of the start site. The two methods employed have
complementary strengths and are broadly applic-
able to mapping promoters/TSSs for trans-spliced
genes in tunicates and in trans-splicing organisms
from other phyla.
INTRODUCTION
Identiﬁcation and mapping of promoters is a key aspect of
gene regulatory studies. Precise localization of promoters
requires determination of transcription start sites (TSSs).
In conventionally-expressed eukaryotic genes TSSs can be
precisely mapped by 50-RACE analysis or other methods
to determine the nucleotide sequence at the 50-end of the
mature mRNA (1). Mapping the mRNA 50-sequence onto
the genome precisely localizes the TSS because the ﬁrst
nucleotide at the 50-end of the nascent pre-mRNA tran-
script is capped with m7G early during gene transcription
and is maintained as the 50-end of the mature mRNA.
However, this simple and direct approach of mature
mRNA 50 sequence analysis is not applicable to TSS
mapping in genes that undergo pre-mRNA spliced-leader
(SL) trans-splicing.
SL trans-splicing, a gene expression mechanism found
in several but not all animal and protist phyla, consists of
the spliceosomal transfer of the 50-segment of a specialized
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sites in the 50-region of target pre-mRNAs (2–4). In
those species in which SL trans-splicing occurs, a signiﬁ-
cant fraction, in some cases the majority, of the total gene
number produce trans-spliced mRNAs. The net result of
SL trans-splicing is the loss of the outron, i.e. the
50-capped pre-mRNA’s original 50-segment upstream
of the trans-splice acceptor site (5), and its replacement
by the 50-capped spliced leader (SL) sequence. Because
the outron is discarded, the 50-end of a mature
trans-spliced mRNA has lost the sequence information
that would otherwise permit TSS mapping. Thus TSS
mapping for trans-spliced genes requires alternative
approaches.
A plausible general approach to determining TSSs for
trans-spliced genes is 50-end sequence analysis, not of the
mature mRNA, but of the discarded outron, or of tran-
scripts in which the outron is retained. Outron-retaining
transcripts could be generated by experimental genetics
approaches that avoid or block SL trans-splicing or, alter-
natively, they may exist at low levels in natural RNA prep-
arations as occasional failures of trans-splicing or as
pre-mRNAs that have not yet undergone trans-splicing.
Experimental genetic approaches and natural minor tran-
script analyses have both been applied to TSS mapping in
previous studies of several nematode trans-spliced genes
(detailed below). We report here the development and ap-
plication of new and general methods based on both ex-
perimental genetics, and natural minor transcript
analyses, and show that these distinct approaches give
precisely concordant results on the trans-spliced
troponin I gene (CiTnI) of the ascidian tunicate chordate
Ciona intestinalis.
Previous studies have established candidate TSSs for
several trans-spliced genes, all in nematodes. TSSs for
the Onchocerca volvulus superoxide dismutase genes
Ov-sod-1, -2, and -3, and glutathione-S-transferase gene
Ov-GST1a, were mapped in studies in which trans-splicing
was experimentally avoided by transcription of recombin-
ant gene constructs in transfected heterologous cell
cultures (6), or in vitro in heterologous nuclear extracts
(7), derived from species in which SL trans-splicing does
not occur, i.e. Homo sapiens or Drosophila melanogaster.
The 50-ends of the non-trans-spliced transcripts thus
produced were mapped by primer-extension reverse tran-
scription, thus identifying TSSs (6,7), albeit with signiﬁ-
cant caveats relating to in vitro methodology and to
uncertain cross-phylum transcriptional ﬁdelity. An alter-
native experimental genetic approach that could block
trans-splicing without resorting to heterologous or
in vitro transcription systems is suggested by a study of
the rol-6 collagen gene of the nematode Caenorhabditis
elegans. Experimental insertion of a splice donor site
into the outron of that gene blocked trans-splicing of the
modiﬁed gene in transgenic nematodes by preferentially
driving cis-splicing from the inserted donor site to the
acceptor site normally used for trans-splicing (8). This
led to the production of rol-6 transcripts that retained
the 50-segment of the wild-type gene’s outron, including
the pre-mRNA’s original 50-end, which was already known
from minor transcript analysis (see below). This approach
of inserting donor sites into trans-spliced gene outrons has
not been used to map unknown TSSs, but it, or other
experimental genetic modiﬁcations that might similarly
block trans-splicing of the modiﬁed gene, could in prin-
ciple be used for that purpose, and we have developed and
applied such a method.
Analysis of low-abundance naturally occurring
outron-retaining transcripts has been used to determine
TSSs for several trans-spliced Caenorhabditis genes: ubi-
quitin UbiA (9), and collagens col-13 (10) and rol-6 (11).
These minor transcripts that presumably represent either
trans-splicing failures or not-yet-trans-spliced mol-
ecules were identiﬁed and characterized through
primer-extension reverse-transcription analysis of RNA
preparations from normal animals. Given the recent de-
velopment of high-throughput sequencing methods for
mRNA 50-ends (12), the direct detection of rare non-
trans-spliced RNA molecules, or of discarded outrons,
in the natural RNA population could represent a conveni-
ent approach for the high-throughput deﬁnition of TSSs
for trans-spliced genes. We report here the use of
high-throughput 50-RACE sequence data for mapping
the TSS of a trans-spliced gene.
We describe here studies of the trans-spliced
C. intestinalis CiTnI gene in which both experimental mo-
lecular genetic studies and analysis of naturally occurring
minor transcripts were used to identify the TSS. We
eliminated trans-splicing of CiTnI experimental constructs
in a Ciona gene expression system using a novel and
simple method based on deletion of the trans-splice
acceptor site and associated branchpoint. Analysis of the
resulting non-trans-spliced transcripts by 50-RACE
identiﬁed a TSS  460bp upstream of the trans-splice
acceptor site. We also searched a data set of C. intestinalis
mRNA oligocapping 50-RACE 50-sequence tags generated
by high-throughput sequencing of normal tailbud
embryos. Although the vast majority of CiTnI transcripts
revealed in this analysis were, as expected, trans-spliced, a
minority  2–3% were non-trans-spliced and the 50-ends of
most of these mapped to exactly the same site we had
previously determined as the TSS by experimental molecu-
lar genetics, conﬁrming the use of that TSS in the en-
dogenous CiTnI gene.
The precise agreement of the two approaches is an
important cross-validation of both methods for TSS
determination. Thus this study deﬁnes a powerful set of
techniques, each with distinct strengths, to be exploited
in future studies of TSSs in Ciona or in other organisms
that carry out SL trans-splicing. Cross-methodology
agreement also strengthens conﬁdence in the CiTnI
TSS determination that is the ﬁrst for a trans-spliced
chordate gene. Identiﬁcation of the TSS allowed us to
perform further experiments to show that the CiTnI
promoter includes a functionally important TATA
element 31nt upstream, and that no essential transcrip-
tional control elements reside within the transcribed part
of the gene. In addition it permitted a comparison with the
previously determined TSSs of two non-trans-spliced
ascidian actin genes, which revealed a number of
similarities.
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DNA constructs
Experimental gene constructs were based on the 50-part of
an allele of the CiTnI troponin I gene of C. intestinalis
[GenBank AF237978 (13–15)] isolated by PCR ampliﬁca-
tion from an Atlantic coast (Massachusetts, USA) animal.
This differs slightly from the allele represented in the
assembled genome sequence [version 1,(16)] derived from
a Paciﬁc coast (California, USA) animal. All coordinates
reported in this paper refer to the ‘Atlantic’ allele except
where indicated by inclusion of the term ‘(P)’ to identify
‘Paciﬁc’ allele coordinates. Table 1 summarizes the
location of key gene features in the two alleles with refer-
ence to the ATG translation start codon.
Vector and LacZ reporter backbone. All constructs were
based on the plasmid vector pBluescript II SK (+)
(Stratagene) into whose SmaI and BamHI sites was
cloned a  3.6kb SmaI/BglII fragment of pSp72-1.27
(17), which contained a promoterless gene encoding a
nuclear-localized derivative of Escherichia coli LacZ
b-galactosidase (18). This vector/reporter backbone is
termed pBnZ. CiTnI DNA segments were introduced in
their natural orientations at the SmaI site in the
50-untranslated region of the pBnZ LacZ reporter gene.
All CiTnI DNA segments were derived from regions
upstream of the protein-coding region. Construct names
identify the ﬁrst and last nucleotides of CiTnI DNA
present, veriﬁed by DNA sequencing and numbered with
respect to the ATG translation start codon.
Large-scale CiTnI deletions. Large-scale deletions were
produced by restriction enzyme cleavage. The parent con-
struct for this series was CiTnI(–1437/–24)nZ, previously
termed 1.5kb TnI/b-gal (15) (note revised nucleotide num-
bering). CiTnI restriction sites and corresponding vector
ends are summarized in Table 2.
Smaller-scale nested end-deletion constructs. The CiTnI
DNA segments in smaller-scale nested-deletion constructs
were generated by PCR ampliﬁcation with Pfu DNA
polymerase using rightward and leftward primers contain-
ing added KpnI and Eco147I sites, respectively. Ampliﬁed
fragments were cut with KpnI and cloned by insertion into
KpnI/SmaI-cut pBluescript II SK (+) after which the
usual  3.6kb LacZ reporter gene-containing SmaI/BglII
fragment was introduced into Eco147I and BamHI sites.
The ‘full-length’ construct for this series was CiTnI( 836/
 335)nZ and the series included 50 deletion construct
CiTnI( 639/ 335)nZ and 30 deletion constructs
CiTnI( 836/ 623)nZ, CiTnI( 836/ 571)nZ, and
CiTnI( 836/ 422)nZ.
CiTnI constructs lacking the transcribed
region. CiTnI( 836/ 523)nZ was prepared by subcloning
into pBluescript II SK (+) a 334-bp KpnI/HincII Ciona
DNA fragment ( 836 to  503) from CiTnI( 836/
 335)nZ, cutting this plasmid intermediate at CiTnI
position  523 with BccI, blunting with Klenow, cutting
with KpnI and recovering the 314-bp BccI/KpnI CiTnI
gene fragment. This was used in a three-way ligation
with the 3.6-kb SmaI/BglII fragment of pSp72-1.27
LacZ and pBluescript II SK (+) cut with KpnI and
BamHI. The TATA-element mutation CiTnI( 836/
 523)mutTATAnZ was produced in parallel by the
same procedure applied to a starting plasmid identical to
CiTnI( 836/ 335)nZ but in which the TATA element
had been mutated by overlap extension PCR (19) as
follows: wt sequence (-555)CTATTTAAGG(-546);
mutant CTAggcAAGG.
Promoter test constucts. This series included a 151-bp
segment of the H. roretzi HrMA4a actin gene [ 216 to
 66, numbered with respect to the TSS identiﬁed by
Hikosaka et al. (20)] ampliﬁed by PCR from a cloned
genomic DNA fragment kindly provided by Dr Yutaka
Satou, Kyoto University. The rightward and leftward
ampliﬁcation primers included added KpnI and HindIII
sites, respectively, and the fragment was cloned into pBnZ
vector HindIII and KpnI sites. The resulting plasmid,
HrnZ, contains the HrMA4a enhancer, and the LacZ
reporter gene, but no eukaryotic promoter. Fragments
Table 2. Restriction sites used for large-scale CiTnI deletion constructs
Construct Upstream CiTnI end (vector end) Downstream CiTnI end (vector end)
CiTnI( 1437/ 24)nZ KpnI (KpnI) Blunted Bpu1102I (SmaI)
CiTnI( 1437/ 383)nZ KpnI (KpnI) Blunted Bpu1102I (SmaI)
CiTnI( 819/ 383)nZ Blunted AatII (blunted KpnI) Blunted Bpu1102I (SmaI)
CiTnI( 1437/ 826)nZ KpnI (KpnI) Blunted AatII (SmaI)
CiTnI( 384/ 24)nZ Blunted Bpu1102I (blunted KpnI) Blunted Bpu1102I (SmaI)
CiTnI( 644/ 383)nZ Blunted XbaI (blunted KpnI) Blunted Bpu1102I (SmaI)
CiTnI( 819/ 641)nZ Blunted AatII (blunted KpnI) Blunted XbaI (SmaI)
Table 1. ATG-based coordinates of CiTnI gene features in ‘Atlantic’ (AF237978.2) and ‘Paciﬁc’ [version 1 genome assembly (16)] alleles
Atlantic Paciﬁc
Trans-splice acceptor nucleotide  64  58(P) major site, with satellite at  55(P)
Transcription start site (determined in this study)  523  521(P)
Length of outron (determined in this study) 459nt 463nt
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inserted between the HrMA4a enhancer and LacZ gene,
in place of the HindIII-to-SmaI region of the vector
polylinker. CiTnI DNA fragments were produced by
PCR ampliﬁcation using rightward and leftward primers
that contained added HindIII and Eco147I sites, respect-
ively, and were joined to the HrMA4a enhancer by a
HindIII/HindIII fusion and to the LacZ reporter gene
by an Eco147I/SmaI fusion.
Gene expression assay
Plasmid DNA constructs (25mg) puriﬁed using the Qiagen
Plasmid Maxikit were introduced by electroporation as
described by Corbo et al. (17) into dechorionated
zygotes produced from adult animals obtained in Rhode
Island and Massachusetts, USA. Following  12h devel-
opment at 18 C, normal-appearing tailbud embryos were
sorted and were either ﬁxed for histochemical detection of
reporter nuclear-localized b-galactosidase by X-Gal
staining (17) or RNA was extracted by lysis with sodium
dodecyl sulfate, phenol and chloroform extraction and
ethanol precipitation. Construct expression levels were
scored as the percentage of normal embryos showing
detectable X-Gal staining. This population parameter
correlated very well with expression levels in individual
embryos. In each X-Gal-treated embryo, b-galactosidase
expression was semiquantitatively assessed as either
negative, or positive in three increasing grades, i.e. + (1
or 2 faintly-stained cells),+ +(1–5 well-stained cells) and
+ + + (6 or more well-stained cells) (see Figure 1). We
noted that with every construct showing expression in
>60% of embryos, the most numerous positive staining
category was+ + +, in every construct showing expression
in 6–60% of embryos the most numerous positive staining
category was + + and in every construct showing expres-
sion in <5% of embryos the most numerous positive
staining category was+(data not shown). Each construct
was tested in two or more independent transformations
and results were concordant and were pooled. For most
constructs, including all constructs showing weak or no
activity, two independent DNA preparations were
analyzed. Several constructs were tested in each experi-
mental session, at least one of which showed strong
activity, thus providing a positive control in parallel for
each inactive or weakly expressed construct. In general,
LacZ expression was in tail muscle cells, with a very low
Figure 1. Gene expression assay. Range of X-Gal staining intensities observed in individual tailbud embryos following zygote electroporation (17) of
CiTnI/nuclear b-galactosidase reporter constructs: (A)+ + +, (B)+ +, (C)+ ,(D) undetectable. DNA constructs used were CiTnI( 836/ 335)nZ (A, B)
and CiTnI( 836/ 571)nZ (C, D). Construct gene expression levels are reported in Figures 2 and 4 as the percentage of normal-appearing embryos
showing detectable staining, a population parameter that correlated well with individual embryo X-Gal staining intensities (see ‘Materials and
Methods’ section).
Nucleic Acids Research,2011, Vol.39, No. 7 2641level in some tail-adjacent cells in the trunk. None of the
mutant constructs tested showed marked ectopic
expression.
TnI/LacZ mRNA 50-RACE. 50-RACE PCR was per-
formed with LacZ-speciﬁc primers for reverse transcrip-
tion (50 CGCTGATTTGTGTAGTC 30) and leftward
PCR synthesis (50 TCACTCCAACGCAGCACCATCA
30, and for nested reampliﬁcation 50 ATCGCACTCCAG
CCAGCTTTCC 30) using the ‘50 RACE System for Rapid
Ampliﬁcation of cDNA Ends Version 2.00 (Invitrogen)
based on oligo(dC)-tailing of ﬁrst-strand cDNA with
terminal deoxynucleotidyl transferase and second-strand
synthesis primed by an anchor sequence linked to
oligo(dI/dG).
High-throughput mRNA 50-RACE analysis
Total RNA from mid-tailbud stage embryos produced
from adults collected in Murotsu harbor, Hyogo, Japan
was subjected to oligo-capping (ligation of an arbitrary
50-anchor sequence to initially capped 50 ends) before
recovery of poly(A)+ RNA and reverse-transcription
using random hexamer primers linked 30 to an arbitrary
30-anchor sequence (21). RNA 50-segments were
PCR-ampliﬁed with 50 and 30 anchor primers and the
products were sequenced using the Illumina Genome
Analyzer (12). Reads were aligned, at a 90% match cri-
terion including indels, with the KH genome assembly
(22) using SeqMap (23) for 34-nt reads and BLAT (24)
for 46-nt reads. This data set included 5216665
uniquely-mapped reads (38% non-trans-spliced and the
remainder SL trans-spliced; 45% 34-nt reads and the re-
mainder 46-nt reads). A full description of this data and
its application to mapping TSSs for non-trans-spliced
genes will be presented elsewhere (K. Okamura et al.,
manuscript in preparation). Here we analyze in detail
the  8 10
3 reads that uniquely mapped to the
trans-spliced CiTnI gene.
RESULTS
Experimental molecular genetic analysis
To identify genetic elements important in transcription of
the muscle-speciﬁc CiTnI gene encoding the contractile
regulatory protein troponin I, we studied expression of
gene constructs in which segments of genomic DNA
including the CiTnI 50-region were linked to an otherwise
promoterless reporter gene encoding a nuclear-localized
derivative of Escherichia coli b-galactosidase (LacZ) (18).
Plasmid DNA was introduced into C. intestinalis zygotes
by electroporation (17) and reporter gene expression was
assessed histochemically in tailbud embryos by X-Gal
staining (Figure 1). Expression levels were scored as the
percentage of normally developed embryos showing de-
tectable expression, which also correlated with expression
levels within individual embryos estimated from the
number of stained cells and their staining intensities (see
‘Materials and Methods’ section). In the parent construct
CiTnI( 1437/ 24)nZ a 1414-bp segment of Ciona CiTnI
DNA (‘Atlantic’ allele, see ‘Materials and Methods’
section) from  1437 to  24 was used (-1 is the nucleotide
preceding the ATG translation start codon). As we have
previously reported (15), this construct (there termed
CiTnI 1.5 nucLacZ) drives high-level LacZ expression
and b-galactosidase activity in a large proportion (100%
in Figure 2) of tailbud stage embryos, speciﬁcally in the
tail muscle cells, indicating that regulatory elements sufﬁ-
cient to drive effective tissue-speciﬁc expression reside
within this 1414-bp segment. This presumably includes
both core promoter/TSS, and any necessary accessory
elements such as enhancers. Because the natural CiTnI
pre-mRNA undergoes SL trans-splicing at position  64
(14) we know the location of the core promoter and TSS
must be upstream of that point, but the loss of the CiTnI
outron that occurs during trans-splicing has to date
precluded precise TSS localization.
Identiﬁcation of an upstream regulatory region including a
promoter. From the parent construct CiTnI( 1437/
 24)nZ we found that sequential deletion ﬁrst of down-
stream region  382 to  24 (construct CiTnI( 1437/
 383)nZ) and then of upstream region  1437 to  820
(construct CiTnI( 819/ 383)nZ) had little effect on
gene expression (Figure 2), indicating that these re-
gions did not contain essential regulatory elements.
These non-essential regions were also found to be incap-
able of driving reporter gene expression on their own
(constructs CiTnI( 1437/ 826)nZ and CiTnI( 384/
 24)nZ, Figure 2). These experiments localized all essen-
tial elements, including enhancer and promoter elements,
to a 437bp regulatory region,  819 to  383. Johnson
et al. (25) identiﬁed a homologous region in the
orthologous C. savignyi troponin I gene (CsTnI), which
they termed the minimal sufﬁcient regulatory region (see
also below).
Upon cleavage of the 437bp CiTnI regulatory region at
an XbaI restriction site we found that neither the
upstream ( 819 to  641) nor the downstream ( 644 to
 383) segments were capable of driving expression on
their own (Figure 2). It seemed possible that a core
promoter on one subfragment had been separated from
an essential enhancer element on the other. To assess this
we devised an enhancer-complementation assay for core
promoter function. This assay was based on a
promoter-dependent enhancer from the HrMA4a muscle
actin gene from the distantly-related ascidian H. roretzi.
(The HrMA4a gene, like C. intestinalis muscle actin genes
(26) does not undergo SL trans-splicing.) The HrMA4a
gene contains a 38-bp muscle-speciﬁc enhancer located
66bp upstream of the TSS (27). We recovered a 151-bp
HrMA4a gene segment containing this enhancer, but not
the promoter, and placed it upstream of the LacZ reporter
gene. As expected, this promoterless construct, HrnZ,
showed no signiﬁcant expression in tailbud embryos
(Figure 2). Thus, it could now be used as a vehicle to
test for core promoter function in segments of the CiTnI
gene regulatory region. Insertion, between the enhancer
and reporter gene in HrnZ, of a PCR-ampliﬁed segment
of the CiTnI regulatory region including the XbaI site and
downstream DNA led to strong muscle-speciﬁc expression
(construct HrMA-CiTnI( 638/ 335)nZ). In contrast,
2642 Nucleic Acids Research, 2011,Vol.39, No. 7insertion of a segment including the XbaI site and
upstream DNA (construct HrMA-CiTnI( 836/ 623)nZ)
resulted in much weaker activity (Figure 2). These results
indicated the presence of a functional core promoter in the
downstream part of the regulatory region,  638 to  335,
and indicated that the upstream part had at best weak core
promoter function.
Precise TSS mapping by experimentally blocking trans-
splicing. We noted that CiTnI constructs lacking the
natural trans-splice acceptor site at  64 and its probable
branchpoint at  82 (14), e.g. construct CiTnI( 819/
 383)nZ, nonetheless showed reporter gene expression
levels similar to the parent construct CiTnI( 1437/
 24)nZ (Figure 2). The absence of the normal trans-splice
acceptor site raised the possibility that the LacZ-encoding
mRNAs produced from these constructs would not be
trans-spliced and would therefore retain the outron
including the original pre-mRNA 50-end, thus permitting
mapping of the TSS. 50-RACE analysis showed that LacZ
mRNAs produced from CiTnI( 819/ 383)nZ in tailbud
embryos were in fact not trans-spliced, but were entirely
colinear with CiTnI genomic DNA extending to a unique
50-end that mapped to genomic position  523, thus
identifying that as a TSS (Figure 3A). Similar
50-RACE analysis of LacZ mRNAs produced by a differ-
ent 30 deletion construct that also removed the nor-
mal trans-splice acceptor site and branchpoint,
CiTnI( 836/ 422)nZ (see below) identiﬁed the same
start site (data not shown). This TSS, at  523, was
located within the region  638 to  335 that we had
identiﬁed in the HrMA4a enhancer-complementation
assay as containing a functional enhancer-dependent
promoter (Figure 2). Interestingly, we also found that
the promoter prediction program NNPP (28) predicted
site  523 as the most likely TSS within the  819 to
 383 sequence of the CiTnI regulatory region.
High-throughput 50-RACE analysis of naturally
occurring minor CiTnI transcripts
Because outron-retaining CiTnI transcripts could be
useful for TSS mapping and might exist at low levels in
normal cells/embryos, we searched for novel minor CiTnI
transcripts in RNA extracted from experimentally unper-
turbed normal tailbud embryos. In a high-throughput
random-primed oligocapping 50-RACE analysis of
tailbud embryo RNA, we found that 8523 reads (of a
genome-wide total of  5 10
6 50-end reads) uniquely
mapped to the 50-region of the CiTnI gene (‘Paciﬁc’
allele present in the version 1 (16) and KH (22) genome
assemblies). Of these, 97.2 % (8284) were SL trans-spliced
50-end reads whose CiTnI-derived sequences 50-mapped to
the known major trans-splice acceptor site at  58(P) and a
satellite site at  55(P) (note Paciﬁc allele numbering
indicated by P in parenthesis; see ‘Materials and
-100 -300 -500 -700 -900 -1100 -1300
construct expression
pBnZ 0% (0/55)
-1437/-24 100% (77/77)
-1437/-383 97% (33/34)
-819/-383 75% (311/417)
-1437/-826 0% (0/148)
-384/-24 <1% (1/146)
-644/-383 0% (0/416)
-819/-641 0% (0/347)
-836/-335 60% (430/711)
-638/-335 <1% (1/200)
-836/-623 0% (0/49)
-638/-335 68% (304/447)
-836/-623 11% (44/389)
HrnZ <1% (1/550)
HrMA4a
enhancer
XbaI
Figure 2. Localization of CiTnI transcriptional elements through large-scale end-deletion analysis. The ﬁgure schematically depicts CiTnI gene DNA
segments. ATG start codon-based coordinates are shown at the top, with the TSS mapped in the present study indicated by a curved arrow. The
XbaI site at  645 to  640 is indicated. Each DNA region tested (black bars) was linked at the right end to a promoterless nuclear b-galactosidase
reporter gene (dashed lines indicate the deleted CiTnI DNA downstream of the region being tested). Recombinant reporter constructs were assayed
as in Figure 1. The column ‘construct’ lists the construct name or the precise range of the CiTnI DNA segment being tested and the column
‘expression’ gives the percentage of normally-developed embryos that showed detectable X-Gal staining (absolute numbers in brackets). CiTnI DNA
segments  638/ 335 and  836/ 623 were tested with and without the HrMA4 enhancer (white bar), as indicated.
Nucleic Acids Research,2011, Vol.39, No. 7 2643Methods’ section). In addition, as shown in Figure 3B and
C, a set of 237 non-trans-spliced 50-end reads also uniquely
mapped to the CiTnI region, including 202 reads that
50-mapped to a single site at position  521(P). Because
such non-trans-spliced transcripts retain the original
pre-mRNA’s 50-end, these reads identify a TSS.
Moreover, the site identiﬁed corresponded to the same
nucleotide that we had previously identiﬁed as the TnI
TSS in the experimental genetic analysis described above
( 523, Atlantic allele numbering, see Figure 3A). The
perfect correspondence of TSS localization through both
experimental genetics and minor transcript analysis adds
conﬁdence to the identiﬁcation of the site as a major TSS
and also indicates the utility of high-throughput analysis
of natural RNA populations in for mapping TSSs for
trans-spliced genes.
Identiﬁcation of a functionally important TATA element
Having conﬁdently identiﬁed a TSS by independent con-
cordant methods, we looked for associated core promoter
elements. To assess the possible presence of downstream
core promoter elements we made a 30 deletion up to but
not including  523, i.e. complete deletion of the
transcribed portion of the gene, retaining only the ﬁrst
nucleotide of the natural CiTnI pre-mRNA. This con-
struct, CiTnI( 836/ 523)nZ, was actively expressed
(Figure 4), indicating that no elements within the
transcribed gene region, except perhaps the ﬁrst nucleo-
tide, were essential for promoter activity. However, larger
30 deletions, to  571 or to  623, that removed the RNA
start site at  523 and nearby upstream DNA, were
inactive [constructs CiTnI( 836/ 571)nZ (Figure 4) and
CiTnI( 836/ 623)nZ (Figure 2)]. Thus DNA upstream
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Figure 3. CiTnI TSS identiﬁcation by experimental molecular genetics and by high-throughput 50-RACE sequence analysis of minor transcripts
present in normal tailbud embryo RNA. Panel (A) TSS mapping by experimental molecular genetics. The panel shows, on the second sequence line,
CiTnI (Atlantic allele) DNA in the region  550 to  491, and beneath it the very similar sequence of the Paciﬁc allele (dots indicate identitity, and
note that the ATG-based coordinates are shifted by 2nt). The topmost sequence line shows the 50-terminal sequence of a  500bp CiTnI-LacZ
mRNA 50-RACE product generated from embryos expressing construct CiTnI( 819/ 383)nZ. Four independent 50-RACE clones all gave the same
sequence, as shown (arbitrary anchor/oligo(dG) sequences introduced during the 50-RACE procedure have been trimmed). The 50-end of all four
products mapped precisely to CiTnI nucleotide  523 (Atlantic allele, corresponding to  521 Paciﬁc allele). Panels (B and C) CiTnI TSS mapping by
high-throughput sequencing of random-primed oligocapping 50-RACE products from naturally occurring transcripts present in normal tailbud
embryo RNA. The panels show the distribution of 50-reads mapping uniquely to CiTnI (Paciﬁc allele) region  550 to  490 (B) or region  900
to  1( C). Panel B corresponds spatially to Panel A, with each histogram bar representing a single nucleotide position. The spatial relationships of
Panels B and C are indicated by dashed lines. In Panel C each histogram bar represents a 10-nt bin. The genomic position mapped for each read
corresponds to the ﬁrst nucleotide of the read for non-trans-spliced reads (black bars), and the ﬁrst nt following the 16-nt SL sequence for
trans-spliced reads (white bars). Note the logarithmic scale of the read count axes; all positions/bins in the region with no bars shown had zero
reads mapped, and the fact that several bins in Panel C contained a single mapped read is shown, arbitrarily, by the shortest black bars visible. All
other bars shown represent two or more mapped reads. Exact numbers for peak counts of non-trans-spliced and trans-spliced reads are indicated.
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includes information required for transcription, including
core promoter function.
This 48-bp region includes the 28-bp segment CH3, one
of four blocks of high C. savignyi/C. intestinalis sequence
conservation noted by Johnson et al. (25) in their study of
the CsTnI gene. The most highly-conserved part of CH3
includes an 8-nt A/T-rich motif, TATTTAAG, beginning
31nt upstream of the TSS we identifed at  523. This
sequence conforms to the TATA element consensus of
Patikoglou et al. (29) T >> c > a   g/A >> t/T >> a 
c/A >> t/T >> a/A >> g > c  t/A  T > g > c/G  A >
c  t, and the extended TATA consensus of Bucher (30),
G C/T/A>t/T/A>t/A T/A/A T/G A/G C/C G/
G C/G C/G C/G C (bolded letters show agreement).
Moreover, the motif’s location is within the known range
of functional TATA elements in vertebrate promoters,
where the ﬁrst T is 22–38nt upstream of the TSS (30),
with the most frequently-observed distances being 30
and 31nt (31). We found that targeted mutation of this
TATA-like element from TATTTAAG to TAggcAAG in
the setting of the CiTnI( 836/ 523)nZ construct greatly
attenuated expression (Figure 4). Thus this upstream
TATA-like element appears to play an important role in
CiTnI promoter function.
DISCUSSION
We report the ﬁrst precise mapping of a TSS for
a trans-spliced gene in the ascidian tunicate chordate
C. intestinalis, an important genetic model organism.
Of more general signiﬁcance, our work establishes two
approaches for TSS mapping in SL trans-spliced genes
that are broadly applicable to tunicates and trans-splicing
organisms in other phyla.
Nature of the CiTnI promoter and outron
Diverse core promoter elements have been identiﬁed in
various eukaryotic genes, including the TATA element
located upstream of the TSS and the Inr element which,
when present, generally includes the TSS (32,33).
Upstream of the experimentally-determined CiTnI TSS
our study revealed a functionally important TATA
element. Although TATA-like elements have been
observed in tunicate genes (25,34) ours is the ﬁrst demon-
stration of a functional TATA element appropriately pos-
itioned vis-a-vis an experimentally-determined TSS. This
TATA element was essential for high-level expression in a
construct lacking all CiTnI sequences downstream of the
TSS. Interestingly, the data of Johnson et al. (25) showed
that mutation of a 20-bp sequence block (scrambled
window 19), including the corresponding TATA element,
inactivated a C. savignyi CsTnI reporter gene construct,
consistent with the important role we document here.
However, further data of Johnson et al. showed that in
a CsTnI construct extending farther downstream, the
entire 27-bp CH3 region including the TATA element
could be deleted without compromising expression. This
could perhaps reﬂect compensation by a downstream
element, or by an upstream element brought closer to
the TSS by the CH3 deletion.
The CiTnI TSS conforms to the general consensus ini-
tiation sequence for mammalian promoters, YR (31)
however there is only limited agreement with the mamma-
lian Inr element functional consensus YYANWYY (35)
(IUPAC nomenclature, matches in bold, and where R
or A is the start nucleotide). We also found no
appropriately-positioned sequences resembling BRE
u,
XCPE1, MTE, or DCE, (32,33) and only a weak resem-
blance of the TATA-ﬂanking downstream sequence to
BRE
d (36), GGAGCTT versus RTDKKKK (matches in
bold). An AGTCA sequence at +32/+36 matches the
DPE consensus RGWYV (32) though it is not positioned
precisely at the+28/+32 location expected for a functional
DPE, and we have shown that no elements downstream
of the ﬁrst transcribed nucleotide are essential for tran-
scription. Thus the only clearly recognizable and
experimentally-validated CiTnI core promoter element
we identify is the TATA element.
Our high-throughput 50-RACE sequence data suggest a
single major TSS in the region, at  523, indicating that
the CiTnI promoter is of the ‘focused’ variety (33). This
site was also precisely predicted by NNPP. The success of
NNPP in predicting an actual TSS for the CiTnI gene
implies conformity of this ascidian promoter to the
NNPP training regime, which is focused on TATA and
Inr elements in vertebrate promoters (28). NNPP’s second
choice was at  576, corresponding to its topscore predic-
tion for the C. savignyi CsTnI gene (25). However, there is
no direct evidence that this upstream site is used as a TSS
in C. savignyi and, because we found that no 50-RACE
reads aligned with that apparently single-copy region of
the CiTnI gene, it does not appear to be used as a signiﬁ-
cant alternative TSS in C. intestinalis tailbud embryos. We
note, as shown in Figure 5, that NNPP’s second-choice
TSS prediction for CsTnI is located very close to the es-
tablished CiTnI TSS, suggesting this as a candidate TSS
for CsTnI. Figure 5 also shows that the established CiTnI
TSS is not located within a highly conserved sequence
block but between two such blocks, CH3 and CH4,
whereas the upstream TATA element is perfectly
conserved within CH3. Stronger conservation of the
TATA element region than of the TSS per se is a
general rule for mammalian TATA-containing
promoters (31).
-400 -500 -600 -700 -800
construct expression
-836/-335 60% (430/711)
-836/-422 42% (182/437)
-836/-523 43% (88/204)
-836/-523
 mutTATA
8% (15/184)
-836/-571 <1% (4/776)
XbaI
Figure 4. Smaller-scale 30 deletion analysis of the transcriptionally-
active region of CiTnI and TATA element mutation. Conventions as
in Figure 2. Site-directed mutation of the TATA element located at
 555 to  546 is symbolized by a diagonally-lined square.
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those of the non-trans-spliced muscle actin genes of the
ascidian H. roretzi, HrMA4a (20,37) and HrMA1a/b (34).
Like the CiTnI TSS, these TSSs have appropriately placed
TATA-like elements (20,34), although their function has
not been investigated by mutation analysis. Apart from
the TATA similarity we also note that the TSSs are
located within a common CATC motif (Figure 6).
Identiﬁcation of the CiTnI TSS also delineates the
outron, i.e. the primary transcript’s 50-segment upstream
of the trans-splice acceptor site. The CiTnI outron is
459nt long (463nt in the Paciﬁc allele). Putative outrons
established by heterologous transcription of nematode
Onchocerca volvulus genes range in length from 12 to
68nt for Ov-sod genes (7) and <79nt for Ov-GST1a, (6).
Outrons in Caenorhabditis, more deﬁnitively delineated on
the basis of natural minor transcript analysis, were 65nt
for collagen col-13 (10), 173nt for collagen rol-6(8), and
450nt for ubiquitin Ubi A (9). Experimental studies in
Caenorhabditis indicate that functional outrons must be
A+U-rich ( 70%) and > 50nt in length (8,38). The
459-nt length of the CiTnI outron, and its 68% A+U
content (versus the 55% A+U content of the adjacent
76-nt ﬁrst-exon sequence downstream of the trans-splice
acceptor site) are consistent with these prior ﬁndings in
nematodes.
One of the functions proposed for SL trans-splicing is
50-untranslated region sanitization, i.e. the removal of
sequence elements present in the outron that may be dele-
terious to mRNA maturation, stability, or function (3). In
this connection, we note that the CiTnI outron contains 3
upstream in-frames, and an additional 3 out-of-frame,
ATG codons, which could perhaps interfere with proper
translation.
General applicability of the TSS mapping methods
Both approaches we employed to map the TSS for the
CiTnI gene—experimental molecular genetics, and analyt-
ical high-throughput 50-RACE sequencing—have broad
potential application to TSS mapping in organisms that
carry out SL trans-splicing.
The experimental molecular genetic approach consisted
of two phases, (i) approximate promoter mapping (using
large-scale deletions coupled with an assay for
enhancer-dependent core promoter function) and (ii)
precise TSS localization by mutational elimination of
trans-splicing leading to outron retention in the mature
mRNA. Both phases could be carried out in any
organism for which gene introduction techniques exist.
In the case of ascidian species (and perhaps other tuni-
cates) for which gene introduction techniques are not
available, it is likely that gene introduction into Ciona
zygotes would be workable. In addition, it is likely that
the Halocynthia HrMA4a muscle actin enhancer would be
able to drive embryonic muscle-speciﬁc expression from
the core promoters of many ascidian/tunicate genes, as
this enhancer drives muscle-speciﬁc expression in
ascidian embryos even from the minimal promoter of a
mammalian virus, SV40 (27). Application of the full ex-
perimental genetic approach to transfectable species from
other trans-splicing phyla may require the identiﬁcation of
comparable promoter-dependent enhancers.
A potential complication of the experimental genetic
approach is the possible unmasking or activation of
upstream cryptic trans-splice acceptor sites upon deletion
of the natural acceptor site and putative branch point.
This would preclude precise mapping of the TSS because
the extreme 50-end of the initial pre-mRNA transcript
would still be discarded during the resultant trans-splicing
reaction (albeit on a shorter than wild-type outron).
Activation of cryptic upstream acceptor sites following
deletion/mutation of the natural trans-splice acceptor
site has been observed in several Caenorhabditis genes
(38) and in trypanosomes (39), and we also observed
this in some CiTnI experimental constructs (data not
shown). However, cryptic acceptors do not appear to be
densely packed within the CiTnI outron sequence, and we
readily found constructs in which no cryptic trans-splicing
occurred and in which the entire construct outron was
maintained in the mature mRNA.
The approach to TSS mapping through high-
throughput 50-RACE sequence analysis of naturally
occurring minor transcripts is independent of the experi-
mental molecular genetic approach. Our analysis
identiﬁed a minority of non-trans-spliced CiTnI tran-
scripts in normal embryos, most of which 50-mapped
precisely to the experimentally determined CiTnI TSS.
-556                                                                    -481
|                                                                          |
TCTATTTAAGGGAGCTTACAGCATCCATCCAACATCGGTAATCgAGAATCTGTTAACCTTGTTTAGTCACAGcGAA
.............CA.G..........AT...T..--------A.C....-...TG......A.........A.T.
|                                                                          |
-545                            ?                                       -479
4 H C 3 H C
Figure 5. The CiTnI TSS is located between highly conserved sequence blocks. The upper sequence shows the C. intestinalis CiTnI gene (Atlantic
allele) in the  556 to  481 regions including the TSS at  523 (arrow). Atlantic and Paciﬁc CiTnI alleles are identical throughout the region, except
for the two bases shown in lower case, where the Paciﬁc allele matches the CsTnI sequence. The lower sequence is that of the C. savignyi orthologue
CsTnI, with identical nucleotides indicated by dots, and gaps by dashes. Highly-conserved sequence blocks CH3 and CH4, identiﬁed by Johnson et al
(25), are boxed. The lower arrow marks the NNPP second-choice TSS prediction for the CsTnI gene region  821 to  354, i.e., position  515, with
the question mark denoting the absence of experimental data to conﬁrm or refute the use of this predicted TSS in the CsTnI gene.
CiTnI  atgttcTATTTAAGggagcttacagcatccatccaaCATC
HrMA4a tttcagTATATAAGccctctatcgttcgcttatattCATC
HrMA1a tgctgaTATAAATAtggcttctatccatctcagaatCATC
Figure 6. Similar features in the core promoter regions of CiTnI and
the H. roretzi actin genes HrMA4a and HrMA1a. Sequences (from
GenBank AF237978.2, S76735.1 and D29014.1) are aligned on the
common CATC sequence that includes the experimentally-identiﬁed
TSSs (bolded nucleotide) (20,34). TATA elements and TSS CATC
motifs are shown in upper case.
2646 Nucleic Acids Research, 2011,Vol.39, No. 7The existence of such molecules, presumably trans-splicing
failures or not-yet-trans-spliced mRNAs/pre-mRNAs,
makes high-throughput 50-RACE a potentially powerful
approach for TSS determination for large numbers of
trans-spliced genes. High-throughput validation methods
would be useful for assessing candidate TSSs mapped
through natural minor transcript analysis. Although the
experimental molecular genetic approach is too
labor-intensive for high-throughput application, an alter-
native validation approach, suggested by the fact that
NNPP predicted the CiTnI TSS precisely, is the use of
NNPP or other promoter prediction programs to give a
rank of conﬁdence to candidate TSSs. An additional po-
tential validation parameter is genomic location an appro-
priate distance upstream of a known trans-splice acceptor
site. The latter may themselves be mapped from the same
high-throughput 50-RACE sequence data (see e.g. ref. 40)
if the readlength is longer than the SL sequence.
The high-throughput 50-RACE method for trans-
spliced gene TSS mapping could be applied to any
organism for which genomic DNA sequence information
is available, including organisms for which no gene
transfer methodology has yet been developed. It could
therefore have a broad and immediate applicability.
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